NIDDM


Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to NIDDM: type 2 diabetes
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for NIDDM

References in periodicals archive ?
On comparing type 1 versus type 2 diabetes, 61% of the type 2 cases tested positive as against 42% of the type 1 for MAU, indicating higher prevalence in NIDDM cases, however, this association was not found to be statistically significant (p=0.
It was a prospective study undertaken to know the effect of IYT on blood sugar levels, glycosylated hemoglobin (HbA1c), and PFT parameters in 50 newly diagnosed patients of borderline NIDDM.
In our study all IDDM patients were well controlled whereas patients with NIDDM showed variable pattern of control of diabetes out of all 34 (63%) patients were well controlled however 20 (37%) patients had uncontrolled diabetes.
Therefore, it can be emphasized that the overall figures regarding the frequency of oral LP in NIDDM are variable.
Type 2 diabetes mellitus (formerly called NIDDM, type II or adult-onset) is characterised by variable insulin resistance in peripheral tissue and insulin deficiency due to an insulin secretory defect of the beta cell.
Onset of NIDDM occurs at least 4-7 years before clinical diagnosis.
The OLETF rats become spontaneously obese and NIDDM with the hyperphagia expressed as a significant increase in the size of meals due to the lack of cholecystokinin-1 (CCK-1) receptors followed by development of hyperlipidemia, fatty liver, and diabetes (Kawano et al.
Bitter Melon (Momordica Charantia): Bitter melon, rumored to be on the hit list of the Codex Alimentarious and thus targeted for being banned, was demonstrated in one study to cause a hypoglycemic response when taken as an aqueous suspension in 86% of NIDDM patients.
This approval is based on the results from the international clinical trial called RENAAL (Reduction of Endpoint in NIDDM with A-II Antagonist Losartan), which covered 1,513 type-2 diabetics (including 96 Japanese patients).
The supporting data come from several clinical trials, including the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study, as well as the Irbesartan Diabetic Nephropa thy Trial (IDNT).
Undiagnosed NIDDM : Clinical a not public health issue.
A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
In the Reduction of End Points in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study, treatment with a RAS blocker halved proteinuria.